ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : anti-inflammatory agent
Australian State/Territory : ACT
Clear All
Filter by Field of Research
Applied immunology (incl. antibody engineering xenotransplantation and t-cell therapies) (1)
Cell Development, Proliferation and Death (1)
Endocrinology (1)
Medical Virology (1)
Oncology And Carcinogenesis (1)
Ophthalmology (1)
Filter by Socio-Economic Objective
Search did not return any results.
Filter by Funding Provider
National Health and Medical Research Council (6)
Filter by Status
Closed (6)
Filter by Scheme
Project Grants (3)
Career Development Fellowships (1)
Program Grants (1)
Programs (1)
Filter by Country
Australia (6)
Filter by Australian State/Territory
ACT (6)
NSW (2)
VIC (2)
QLD (1)
SA (1)
WA (1)
  • Researchers (0)
  • Funded Activities (6)
  • Organisations (0)
  • Funded Activity

    Novel Functional Testing For Macular Degeneration

    Funder
    National Health and Medical Research Council
    Funding Amount
    $540,360.00
    Summary
    The vision we rely on every day to read and recognise faces depends upon the health of the central portion of our retina, the macula. Age-related Macular Degeneration (AMD) is the leading cause of blindness in Australia and the western world. Researchers at the Australian National University are collaborating to bring a new test for AMD severity to the market within 3 years. The objective is to provide doctors with a rapid, cost-effective tool to help them manage treatment.
    More information
    Funded Activity

    Improving Treatment Strategies For Chronic Alphaviral Arthritic Diseases

    Funder
    National Health and Medical Research Council
    Funding Amount
    $643,624.00
    Summary
    Chikungunya virus and Ross River virus cause epidemics of acute and chronic arthritic disease in humans, which is often poorly managed with current treatments. This grant seeks to understand the mechanisms that give rise to disease in order to identify improved treatment strategies. Both the persistence of viral replication in joint tissues and unnecessary inflammatory responses appear to be important factors driving chronic disease.
    More information
    Funded Activity

    Roles Of Impaired Apoptosis And Differentiation In Tumourigenesis And Therapy

    Funder
    National Health and Medical Research Council
    Funding Amount
    $21,656,910.00
    Summary
    The ten scientific laboratories in this program have joined forces to investigate two ways in which tumours develop. Both are of particular interest, because they suggest new ways in which cancer might be overcome. Most of our tissues are continually renewed throughout life by production of new cells. Therefore many of the old cells in each tissue must die off to maintain the proper cell numbers. To eliminate cells that are no longer needed or have become damaged, the body has developed a remark .... The ten scientific laboratories in this program have joined forces to investigate two ways in which tumours develop. Both are of particular interest, because they suggest new ways in which cancer might be overcome. Most of our tissues are continually renewed throughout life by production of new cells. Therefore many of the old cells in each tissue must die off to maintain the proper cell numbers. To eliminate cells that are no longer needed or have become damaged, the body has developed a remarkable cell suicide process termed apoptosis. Unfortunately, however, occasionally a random accident to the genes in one of our cells prevents the machinery for apoptosis from being turned on. In that case, the cell will not die when it should and, by continually dividing, it may eventually give rise to a cancer. Since most cancer cells still retain most of the machinery for apoptosis, however, a drug that could switch on this natural cell death machinery would provide a promising new approach to cancer therapy. Identifying and developing such drugs is one major long-term goal of this program. The other focus of our program concerns stem cells. These are rare cells with the remarkable ability to generate an entire tissue. For example, one of our laboratories has identified stem cells that can generate all the cells in the breast. The almost unlimited regenerative capacity of stem cells has a built-in danger. If a stem cell acquires the ability to proliferate excessively, it can go on to form a tumour. Indeed, many cancer researchers now suspect that rare stem cells within a tumour cause its inexorable growth. If tumour growth is maintained by stem cells, it will be essential to develop new forms of therapy that target these rare cancer stem cells rather than merely the bulk of the tumour cells. This is another key long-term goal of our program.
    Read more Read less
    More information
    Funded Activity

    Testosterone Intervention For The Prevention Of Diabetes Mellitus In High Risk Men: A Randomised Trial

    Funder
    National Health and Medical Research Council
    Funding Amount
    $5,054,654.00
    Summary
    Type 2 diabetes (T2DM) is increasingly common, costly and deadly. Some men at risk of T2DM have low testosterone (T) levels. Our preliminary data suggests that T treatment may prevent the development of T2DM, and improve cardiovascular and sexual function, body composition and bone density, and mood. This remains to be fully tested in a randomized placebo-controlled trial, and this project will do so in a 2-year study of T treatment compared to placebo in men at risk of T2DM participating in a l .... Type 2 diabetes (T2DM) is increasingly common, costly and deadly. Some men at risk of T2DM have low testosterone (T) levels. Our preliminary data suggests that T treatment may prevent the development of T2DM, and improve cardiovascular and sexual function, body composition and bone density, and mood. This remains to be fully tested in a randomized placebo-controlled trial, and this project will do so in a 2-year study of T treatment compared to placebo in men at risk of T2DM participating in a lifestyle program.
    Read more Read less
    More information
    Funded Activity

    Novel Insights Into The Mechanisms Of How Viruses Cause Arthritis/Arthralgia

    Funder
    National Health and Medical Research Council
    Funding Amount
    $78,187.00
    Summary
    Viruses cause many diseases today and new viruses emerge to post threats to future health and well being. The proposed work investigates how viruses cause disease in people, particularly how viral infections can lead to arthritis or muscle pain. This understanding will be used in the development of new prevention strategies and treatments.
    More information
    Funded Activity

    Developmental Therapeutics For The Treatment Of Gastrointestinal Cancers

    Funder
    National Health and Medical Research Council
    Funding Amount
    $5,392,649.00
    More information

    Showing 1-6 of 6 Funded Activites

    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback